cqdm’s quantum leap pharma-led funding program for drug discovery research helps smes or canadian universities achieve innovative translational biopharmaceutical research projects. projects selected as part of the quantum leap program focus on developing cutting-edge technologies with the potential to significantly advance the r&d activities of cqdm’s pharmaceutical members. quantum leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

the purpose of this program is to fund research projects that inform the development of next-generation accessibility standards. these are model standards that fall within federal areas of responsibility. your research project must align with this purpose.

projects under this program must involve people with disabilities, experts with disabilities and lived experience, other experts, and organizations. your expression of interest must show how your project will identify, remove, and prevent barriers to accessibility.

together with cassie + friends, brain canada is thrilled to launch the addressing mental health in paediatric rheumatic diseases team grants. this funding opportunity aims to support research that will improve our understanding of the prevention, diagnosis, and/or treatment of mental illnesses in children and young adults aged 0 to 27 years with rheumatic diseases. 

the weston family foundation, through its proof-of-principle program, funds canadian scientists performing high-risk, high-reward translational research that leverages the microbiome towards improving human health.

the human body is host to trillions of microbes. research suggests that these organisms play important roles in health and disease and have a profound bearing on nutrition. the foundation is pleased to announce the launch of a new funding opportunity. the proof-of-principle 2023 program will support high-impact projects that seek to leverage the microbiome to maximize the health benefits of precision nutrition.

eligibile projects will:

• leverage the microbiome to maximize the benefits of nutrition in people.
• evaluate microbiome heterogeneity and how it impacts nutrient metabolism in humans.

please refer to the program details for a full description.

funding available per project: up to $300,000 over a maximum of 30 months.

the pradeep khare memorial scholarship was established in 2016 by pradeep’s family. it is awarded in memory of pradeep, an immigrant to canada in 1972, who worked hard to establish a fulfilling life in canada, give back to the community, and move up to senior positions within the canadian government. in memory of pradeep, this scholarship is awarded to a student who demonstrates leadership, drive, self-reflection, academic excellence, and a desire to use their privileged education in order to give back to their community, and who has financial need.

the objective of idea to innovation (i2i) grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector, and to promote its transfer to a new or established canadian company. i2i grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. this is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.

the goal of this funding opportunity is to support research that strengthens the health workforce, which is an essential component of advancing the quadruple aim and health equity for health system transformation.

this funding opportunity is composed of two types of grants:

• implementation science teams (ists)
• evidence support and knowledge mobilization (eskm) hub

the specific objectives of this funding opportunity are to:

• develop a platform to support pediatric rare disease clinical trials in canada in an accessible manner, for both the profit and not-for-profit sectors, to maximize the impact and benefit of the research for clinical practice, policy, and future research;
• increase the capacity to perform rare disease clinical trials in canada by offering training and mentorship opportunities for researchers, patients, clinicians and other relevant stakeholders;
• attract international clinical trials, increasing investments in canada and providing earlier access to innovative therapies to people living in canada;
• foster diversity and inclusion in and improve access to clinical trials;
• implement processes to acquire data from clinical trials, real world registries, health economics evaluation, and post-marketing surveillance to inform assessment reviews throughout the whole drug/therapy cycle; and,
• increase the number of new rare disease drug submissions for authorization of commercialization to health canada.

these objectives are to be supported by the following key design elements/components which must be included in the network:

• governance: the governance structure should ensure a clear and transparent mechanism for decision-making, to ensure outcomes for rare diseases patients are maximized. the governance structure must include a mechanism for engaging key stakeholders and collaborators from academic, clinical, not-for-profit, industry, government and other relevant sectors, and patients and their families/caregivers. mechanisms for independent scientific advice and advice on ethical, legal including identifying and advising on scientific and/or equity gaps in the network, must also be defined as well as measures to address/mitigate issues such as conflict of interest.
• pan-canadian representation: the network must include team members from across canada to ensure appropriate pan-canadian representation and capacity building to work on research that will impact the quality of life and quality of services for children affected by rare diseases and their families/caregivers.
• international linkages: the network must foster close engagement with international rare diseases clinical networks, including clinical trials and related knowledge mobilization activities to maximize the impact of the network.
• patient and citizen engagement: the network must outline processes and principles for meaningful engagement of patients and their families/caregivers in core activities and governance. for information regarding principles of engagement, including approaches to compensation of patients/citizens, please refer to the spor patient engagement framework.
• knowledge mobilization: in collaboration with partners and existing canadian platforms, the network will take an impact-oriented approach at all stages of the project, including but not limited to priority-setting and co-creation with knowledge users (e.g., patients and health professionals).
• data governance: the network must have a robust strategy for how data will be stored, linked and shared among network partners.  research data managed by the network should be as fair as possible – findable, accessible, interoperable, and reusable – and the data governance plan should outline how the fair principles will be applied.
• sex and gender differences, exist in pediatric research, making these issues an important component of this research initiative. cihr requires that applicants consider sex as a biological variable and gender as a socio-cultural factor in the network and related research activities and encourages applicants to consider sex and gender through an intersectional lens where appropriate.
• health disparities and equity, diversity and inclusion (edi): the network is required to ensure an appropriate representation of groups underrepresented in science, and those with a diversity of experiences, within the team and across the network. this includes ensuring the research environment is supportive and any systemic barriers are addressed effectively and swiftly (see the best practices in equity, diversity and inclusion in research for guidance and examples of systemic barriers)

the objectives of the yukon neihr centre development grant are to:

• enable first nations, inuit, and/or métis communities to determine readiness, priority areas of interest and capacity within relevant communities to create an indigenous health research network based in the yukon;
• assess the viability of a research network and a partnership of creating a capacity building network among first nations, inuit, and/or métis communities and potential team members including researchers, knowledge-users and/or partners;
• identify the research aim, objectives and/or questions or emerging issues and priorities that could form the basis of a yukon neihr centre operating grant application;
• enable indigenous peoples and other members of the research team to engage in development efforts to successfully compete for a yukon neihr centre operating grant.

description

the forest sector investment and innovation program provides funding for strategic investments in the forest sector that:

• enhance competitiveness
• support new market access
• provide benefits to ontario’s broader forest sector
• strengthen regional economies

support is available under two project categories:

• business projects
• collaboration projects